John Overdeck’s Bristol-Myers Squibb BMY Stock Holding History

John Overdeck’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$403K	Sell	7,000 -28,700	-80%	-$1.65M	﹤0.01%	4324
2026 Q1	$2.17M	Buy	+35,700	New	+$2.08M	﹤0.01%	2700
2022 Q1	–	Sell	-174,700	Closed	-$10.9M	–	2817
2021 Q4	$10.9M	Buy	174,700 +161,900	+1,265%	+$9.5M	0.02%	739
2021 Q3	$757K	Sell	12,800 -68,200	-84%	-$4.49M	﹤0.01%	2880
2021 Q2	$5.41M	Sell	81,000 -124,200	-61%	-$8.1M	0.01%	1149
2021 Q1	$13M	Buy	205,200 +187,500	+1,059%	+$11.7M	0.03%	600
2020 Q4	$1.1M	Sell	17,700 -71,900	-80%	-$4.42M	﹤0.01%	1922
2020 Q3	$5.4M	Buy	+89,600	New	+$5.39M	0.02%	764
2020 Q2	–	Sell	-271,500	Closed	-$15.1M	–	2962
2020 Q1	$15.1M	Buy	271,500 +206,200	+316%	+$12.6M	0.12%	169
2019 Q4	$4.19M	Sell	65,300 -125,000	-66%	-$7.16M	0.01%	1075
2019 Q3	$9.65M	Buy	190,300 +144,500	+316%	+$6.79M	0.03%	559
2019 Q2	$2.08M	Buy	45,800 +26,900	+142%	+$1.25M	0.01%	1423
2019 Q1	$902K	Buy	+18,900	New	+$941K	﹤0.01%	1896
2018 Q4	–	Sell	-16,500	Closed	-$1.02M	–	2997
2018 Q3	$1.02M	Sell	16,500 -127,600	-89%	-$7.57M	﹤0.01%	1964
2018 Q2	$7.97M	Buy	144,100 +78,700	+120%	+$4.25M	0.02%	769
2018 Q1	$4.14M	Buy	+65,400	New	+$4.21M	0.01%	1065
2017 Q2	–	Sell	-54,900	Closed	-$2.98M	–	2962
2017 Q1	$2.98M	Buy	54,900 +700	+1%	+$38.4K	0.01%	1212
2016 Q4	$3.17M	Sell	54,200 -115,800	-68%	-$6.33M	0.01%	1149
2016 Q3	$9.17M	Buy	170,000 +99,000	+139%	+$6.36M	0.03%	580
2016 Q2	$5.22M	Buy	71,000 +26,200	+58%	+$1.85M	0.02%	756
2016 Q1	$2.86M	Buy	44,800 +2,800	+7%	+$177K	0.01%	968
2015 Q4	$2.89M	Buy	+42,000	New	+$2.78M	0.01%	901

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

John Overdeck's BMY Position: Q2 2026 in Review

John Overdeck reduced its Bristol-Myers Squibb (BMY) stake by 13% in Q2 2026, selling an estimated $83.2M and leaving 10,085,383 shares worth $581M. The position accounts for 0.42% of the portfolio, ranked #36.

John Overdeck first reported a position in BMY in Q3 2013 and has held it in 46 quarters since. The position peaked at $700M in Q1 2026. 2,506 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

John Overdeck held 10,085,383 shares of Bristol-Myers Squibb worth $581M as of Q2 2026.
John Overdeck sold 1,449,723 Bristol-Myers Squibb shares in Q2 2026, an estimated $83.2M.
Bristol-Myers Squibb made up 0.42% of John Overdeck's portfolio in Q2 2026, its #36 holding.
John Overdeck first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 46 quarters since.
John Overdeck's Bristol-Myers Squibb position peaked at $700M in Q1 2026.
2,506 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.